Annual Shareholders Equity
$902.34 M
-$39.20 M-4.16%
December 31, 2024
Summary
- As of March 13, 2025, NEO annual stockholders equity is $902.34 million, with the most recent change of -$39.20 million (-4.16%) on December 31, 2024.
- During the last 3 years, NEO annual shareholders equity has fallen by -$205.94 million (-18.58%).
- NEO annual shareholders equity is now -18.58% below its all-time high of $1.11 billion, reached on December 31, 2021.
Performance
NEO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$902.34 M
-$5.87 M-0.65%
December 31, 2024
Summary
- As of March 13, 2025, NEO quarterly stockholders equity is $902.34 million, with the most recent change of -$5.87 million (-0.65%) on December 31, 2024.
- Over the past year, NEO quarterly shareholders equity has dropped by -$21.07 million (-2.28%).
- NEO quarterly shareholders equity is now -21.42% below its all-time high of $1.15 billion, reached on June 30, 2021.
Performance
NEO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NEO Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -4.2% | -2.3% |
3 y3 years | -18.6% | -4.8% |
5 y5 years | +77.8% | +77.8% |
NEO Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -18.6% | at low | -18.6% | at low |
5 y | 5-year | -18.6% | +77.8% | -21.4% | +78.7% |
alltime | all time | -18.6% | >+9999.0% | -21.4% | >+9999.0% |
NeoGenomics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $902.34 M(-4.2%) | $902.34 M(-0.6%) |
Sep 2024 | - | $908.21 M(-0.8%) |
Jun 2024 | - | $915.88 M(-0.8%) |
Mar 2024 | - | $923.41 M(-1.9%) |
Dec 2023 | $941.54 M(-5.7%) | $941.54 M(-0.6%) |
Sep 2023 | - | $947.43 M(-0.9%) |
Jun 2023 | - | $956.19 M(-1.9%) |
Mar 2023 | - | $974.46 M(-2.4%) |
Dec 2022 | $998.02 M(-9.9%) | $998.02 M(-1.5%) |
Sep 2022 | - | $1.01 B(-2.9%) |
Jun 2022 | - | $1.04 B(-2.9%) |
Mar 2022 | - | $1.08 B(-3.0%) |
Dec 2021 | $1.11 B(+59.6%) | $1.11 B(-2.5%) |
Sep 2021 | - | $1.14 B(-1.0%) |
Jun 2021 | - | $1.15 B(+36.1%) |
Mar 2021 | - | $843.71 M(+21.5%) |
Dec 2020 | $694.29 M(+36.8%) | $694.29 M(+4.2%) |
Sep 2020 | - | $666.36 M(+1.9%) |
Jun 2020 | - | $654.23 M(+29.5%) |
Mar 2020 | - | $505.04 M(-0.5%) |
Dec 2019 | $507.41 M(+58.3%) | $507.41 M(+2.1%) |
Sep 2019 | - | $497.01 M(+1.5%) |
Jun 2019 | - | $489.73 M(+51.2%) |
Mar 2019 | - | $323.85 M(+1.1%) |
Dec 2018 | $320.44 M(+56.6%) | $320.44 M(+5.6%) |
Sep 2018 | - | $303.56 M(+84.9%) |
Jun 2018 | - | $164.21 M(-21.1%) |
Mar 2018 | - | $208.02 M(+1.7%) |
Dec 2017 | $204.58 M(+9.6%) | $204.58 M(+2.5%) |
Sep 2017 | - | $199.66 M(+1.6%) |
Jun 2017 | - | $196.57 M(+1.3%) |
Mar 2017 | - | $194.02 M(+4.0%) |
Dec 2016 | $186.60 M(-21.6%) | $186.60 M(-24.2%) |
Sep 2016 | - | $246.09 M(+1.1%) |
Jun 2016 | - | $243.37 M(+1.3%) |
Mar 2016 | - | $240.17 M(+0.9%) |
Dec 2015 | $238.11 M(+294.2%) | $238.11 M(+285.0%) |
Sep 2015 | - | $61.85 M(+1.6%) |
Jun 2015 | - | $60.87 M(+1.2%) |
Mar 2015 | - | $60.16 M(-0.4%) |
Dec 2014 | $60.41 M(+178.2%) | $60.41 M(+2.3%) |
Sep 2014 | - | $59.06 M(+155.3%) |
Jun 2014 | - | $23.13 M(+2.8%) |
Mar 2014 | - | $22.50 M(+3.6%) |
Dec 2013 | $21.71 M(+135.6%) | $21.71 M(+6.8%) |
Sep 2013 | - | $20.33 M(+4.6%) |
Jun 2013 | - | $19.44 M(+3.2%) |
Mar 2013 | - | $18.83 M(+104.3%) |
Dec 2012 | $9.22 M | $9.22 M(-0.1%) |
Sep 2012 | - | $9.22 M(-5.1%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | $9.72 M(+12.1%) |
Mar 2012 | - | $8.67 M(+47.0%) |
Dec 2011 | $5.90 M(+88.1%) | $5.90 M(+10.0%) |
Sep 2011 | - | $5.36 M(+1.3%) |
Jun 2011 | - | $5.29 M(-1.8%) |
Mar 2011 | - | $5.39 M(+71.8%) |
Dec 2010 | $3.13 M(-44.4%) | $3.13 M(-7.1%) |
Sep 2010 | - | $3.38 M(-23.0%) |
Jun 2010 | - | $4.38 M(-14.1%) |
Mar 2010 | - | $5.10 M(-9.6%) |
Dec 2009 | $5.64 M(+275.9%) | $5.64 M(-19.9%) |
Sep 2009 | - | $7.05 M(+200.2%) |
Jun 2009 | - | $2.35 M(+2.4%) |
Mar 2009 | - | $2.29 M(+52.8%) |
Dec 2008 | $1.50 M(-35.4%) | $1.50 M(-39.6%) |
Sep 2008 | - | $2.49 M(+6.7%) |
Jun 2008 | - | $2.33 M(+8.3%) |
Mar 2008 | - | $2.15 M(-7.3%) |
Dec 2007 | $2.32 M(+4160.7%) | $2.32 M(-39.9%) |
Sep 2007 | - | $3.86 M(-11.2%) |
Jun 2007 | - | $4.35 M(+450.9%) |
Mar 2007 | - | $789.70 K(+1349.0%) |
Dec 2006 | $54.50 K(-105.5%) | $54.50 K(-76.0%) |
Sep 2006 | - | $227.00 K(-317.2%) |
Jun 2006 | - | -$104.50 K(-60.4%) |
Mar 2006 | - | -$264.20 K(-73.4%) |
Dec 2005 | -$994.90 K(+133.2%) | -$994.90 K(+41.5%) |
Sep 2005 | - | -$702.90 K(+43.7%) |
Jun 2005 | - | -$489.10 K(+49.3%) |
Mar 2005 | - | -$327.50 K(-23.2%) |
Dec 2004 | -$426.70 K(+16.0%) | -$426.70 K(+211.9%) |
Sep 2004 | - | -$136.80 K(-62.2%) |
Jun 2004 | - | -$361.50 K(-26.2%) |
Mar 2004 | - | -$490.00 K(+33.2%) |
Dec 2003 | -$367.80 K(-1678.5%) | -$367.80 K(+64.3%) |
Sep 2003 | - | -$223.80 K(+135.3%) |
Jun 2003 | - | -$95.10 K(+18.9%) |
Mar 2003 | - | -$80.00 K(-443.3%) |
Dec 2002 | $23.30 K(-122.2%) | $23.30 K(-75.3%) |
Sep 2002 | - | $94.40 K(-166.4%) |
Jun 2002 | - | -$142.10 K(-26.7%) |
Mar 2002 | - | -$193.80 K(+84.7%) |
Dec 2001 | -$104.90 K(-15.9%) | -$104.90 K(-53.8%) |
Sep 2001 | - | -$227.10 K(-29.8%) |
Jun 2001 | - | -$323.30 K(-31.2%) |
Mar 2001 | - | -$469.70 K(+276.4%) |
Dec 2000 | -$124.80 K | -$124.80 K(-77.2%) |
Sep 2000 | - | -$548.40 K(+163.3%) |
Jun 2000 | - | -$208.30 K(+200.1%) |
Mar 2000 | - | -$69.40 K |
FAQ
- What is NeoGenomics annual stockholders equity?
- What is the all time high annual shareholders equity for NeoGenomics?
- What is NeoGenomics annual shareholders equity year-on-year change?
- What is NeoGenomics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for NeoGenomics?
- What is NeoGenomics quarterly shareholders equity year-on-year change?
What is NeoGenomics annual stockholders equity?
The current annual shareholders equity of NEO is $902.34 M
What is the all time high annual shareholders equity for NeoGenomics?
NeoGenomics all-time high annual stockholders equity is $1.11 B
What is NeoGenomics annual shareholders equity year-on-year change?
Over the past year, NEO annual stockholders equity has changed by -$39.20 M (-4.16%)
What is NeoGenomics quarterly stockholders equity?
The current quarterly shareholders equity of NEO is $902.34 M
What is the all time high quarterly shareholders equity for NeoGenomics?
NeoGenomics all-time high quarterly stockholders equity is $1.15 B
What is NeoGenomics quarterly shareholders equity year-on-year change?
Over the past year, NEO quarterly stockholders equity has changed by -$21.07 M (-2.28%)